WO2003083081A3 - Lipid-associated molecules - Google Patents

Lipid-associated molecules Download PDF

Info

Publication number
WO2003083081A3
WO2003083081A3 PCT/US2003/009755 US0309755W WO03083081A3 WO 2003083081 A3 WO2003083081 A3 WO 2003083081A3 US 0309755 W US0309755 W US 0309755W WO 03083081 A3 WO03083081 A3 WO 03083081A3
Authority
WO
WIPO (PCT)
Prior art keywords
lipam
lipid
associated molecules
polynucleotides
agonists
Prior art date
Application number
PCT/US2003/009755
Other languages
French (fr)
Other versions
WO2003083081A2 (en
Inventor
Brooke M Emerling
Joseph P Marquis
Narinder K Chawla
Soo Y Lee
Brendan M Duggan
Bridget A Warren
Mariah R Baughn
Ernestine A Lee
Jennifer A Griffin
Amy E Kable
Vicki S Elliott
Hsin-Ru Chang
Sally Lee
Jayalaxmi Ramkumar
Sean A Bulloch
April J A Hafalia
Reena Khare
Xin Jiang
Alan A Jackson
Original Assignee
Incyte Corp
Brooke M Emerling
Joseph P Marquis
Narinder K Chawla
Soo Y Lee
Brendan M Duggan
Bridget A Warren
Mariah R Baughn
Ernestine A Lee
Jennifer A Griffin
Amy E Kable
Vicki S Elliott
Hsin-Ru Chang
Sally Lee
Jayalaxmi Ramkumar
Sean A Bulloch
April J A Hafalia
Reena Khare
Xin Jiang
Alan A Jackson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp, Brooke M Emerling, Joseph P Marquis, Narinder K Chawla, Soo Y Lee, Brendan M Duggan, Bridget A Warren, Mariah R Baughn, Ernestine A Lee, Jennifer A Griffin, Amy E Kable, Vicki S Elliott, Hsin-Ru Chang, Sally Lee, Jayalaxmi Ramkumar, Sean A Bulloch, April J A Hafalia, Reena Khare, Xin Jiang, Alan A Jackson filed Critical Incyte Corp
Priority to AU2003230760A priority Critical patent/AU2003230760A1/en
Publication of WO2003083081A2 publication Critical patent/WO2003083081A2/en
Publication of WO2003083081A3 publication Critical patent/WO2003083081A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Various embodiments of the invention provide human lipid-associated molecules (LIPAM) and polynucleotides which identify and encode LIPAM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LIPAM.
PCT/US2003/009755 2002-03-29 2003-03-27 Lipid-associated molecules WO2003083081A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003230760A AU2003230760A1 (en) 2002-03-29 2003-03-27 Lipid-associated molecules

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US36872202P 2002-03-29 2002-03-29
US60/368,722 2002-03-29
US37757602P 2002-05-03 2002-05-03
US60/377,576 2002-05-03
US39393402P 2002-07-05 2002-07-05
US60/393,934 2002-07-05
US41426902P 2002-09-27 2002-09-27
US60/414,269 2002-09-27

Publications (2)

Publication Number Publication Date
WO2003083081A2 WO2003083081A2 (en) 2003-10-09
WO2003083081A3 true WO2003083081A3 (en) 2004-07-08

Family

ID=28679085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/009755 WO2003083081A2 (en) 2002-03-29 2003-03-27 Lipid-associated molecules

Country Status (2)

Country Link
AU (1) AU2003230760A1 (en)
WO (1) WO2003083081A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972802B2 (en) 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"GLY-GLN", SIGMA CHEMICAL COMPANY CATALOG, 1993, pages 1089, XP002975225 *

Also Published As

Publication number Publication date
WO2003083081A2 (en) 2003-10-09
AU2003230760A8 (en) 2003-10-13
AU2003230760A1 (en) 2003-10-13

Similar Documents

Publication Publication Date Title
WO2003104410A3 (en) Enzymes
WO2003052075A3 (en) Enzymes
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2002063005A3 (en) Lipid-associated molecules
WO2003042357A3 (en) Enzymes
WO2004044165A3 (en) Lipid-associated proteins
WO2004009797A3 (en) Protein modification and maintenance molecules
WO2003063688A3 (en) Protein modification and maintenance molecules
WO2004053068A3 (en) Protein modification and maintenance molecules
WO2004001008A3 (en) Kinases and phosphatases
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2003062391A3 (en) Structural and cytoskeleton-associated proteins
WO2002101008A3 (en) Intracellular signaling molecules
WO2004003162A3 (en) Enzymes
WO2003031939A3 (en) Protein modification and maintenance molecules
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003072729A3 (en) Enzymes
WO2003100016A3 (en) Protein modification and maintenance molecules
WO2003093439A3 (en) Enzymes
WO2003083082A3 (en) Enzymes
WO2004042022A3 (en) Kinases and phosphatases
WO2003083084A3 (en) Protein modification and maintenance molecules
WO2003083081A3 (en) Lipid-associated molecules
WO2004022705A3 (en) Neurotransmission-associated proteins
WO2003025150A3 (en) Lipid-associated molecules

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP